The Senate confirmed Robert F. Kennedy Jr. as secretary of the Department of Health and Human Services. Healthcare leaders ...

House Republicans introduced a proposal seeking to cut Medicaid spending by hundreds of billions of dollars. Healthcare ...

Senators John Kennedy (R-Louisiana) and Eric Schmitt (R-Missouri) introduced a bill last week that would require “able-bodied adults” without dependents to work or volunteer for at least 20 hours per ...

CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the ...

Digital health apps have faced serious headwinds in recent years amid dried-up funding and macroeconomic challenges. New digital products angling to make inroads in today’s markets must do so on ...

Fraud, waste and abuse (FWA) schemes like unnecessary genetic testing, fake Covid-19 testing and inappropriate billing of behavioral health services continue to plague the healthcare industry ...

A clinical study testing a Pliant Therapeutics drug once considered a promising prospect for treating a fatal lung disorder is now on pause at the recommendation of independent outside observers.

Given the remarkable advances seen with gene therapies for sickle cell disease (SCD), it may seem counterintuitive to suggest the space may be in need of more therapies that have already been ...

Last week, no one who works in healthcare could escape the nonstop breaking news from the RFK’s hearing, which raised awareness to several issues currently plaguing our healthcare system.

Vertex Pharmaceuticals dominates the market for cystic fibrosis drugs, but Sionna Therapeutics contends the pharma company’s products still have efficacy and safety limitations. Sionna has ...